Lancashire and South Cumbria
Formulary
Formulary
15 Anaesthesia
15-01-04-04 Other drugs for sedation
| Clonidine |
|
Formulary
|
Injection 150microgram/mL |
 Lancashire and South Cumbria Critical Care Medicines Information |
|
| Dexmedetomidine Dexdor® |
|
Formulary
|
Injection 100micrograms/mL 2mL & 4mL ampoules Dexmedetomidine should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management. |
LSCMMG: Critical Care Medicines Information MHRA/CHM advice: Dexmedetomidine: clinical trial finds increased risk of mortality in intensive care unit (ICU) patients aged 65 years or younger (June 2022) |
|
|
Links
- Lancashire and South Cumbria Critical Care Medicines Information
- LSCMMG: Critical Care Medicines Information
- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA/CHM advice: Dexmedetomidine: clinical trial finds increased risk of mortality in intensive care unit (ICU) patients aged 65 years or younger (June 2022)
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE TA854 Esketamine nasal spray for treatment-resistant depression
- NICE TA899: Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)